Center of Medicine, All-Russian Research Institute of Medicinal and Aromatic Plants (VILAR), Grina Street 7, Moscow, 117216, Russia.
FSBI "Research Institute of Human Morphology", 3 Tsyurupy St., Moscow, 117418, Russia.
BMC Complement Med Ther. 2021 Jan 13;21(1):31. doi: 10.1186/s12906-020-03184-z.
The dysfunction of the thyroid gland is a common medical condition. Nowadays, patients frequently use medicinal herbs as complementary or alternative options to conventional drug treatments. These patients may benefit from treatment of thyroid dysfunctions with Potentilla alba L. preparations. While it has been reported that Potentilla alba preparations have low toxicity, nothing is known about their ability to affect reproductive functions in patients of childbearing age.
Male Wistar rats were orally treated with a thyrotrophic botanical drug, standardized Potentilla alba Dry Extract (PADE), at doses 8 and 40 times higher than the median therapeutic dose recommended for the clinical trials, for 60 consecutive days. Male Wistar rats receiving water (HO) were used as controls. After completing treatment, half of the PADE-treated and control males were used to determine PADE gonadotoxicity, and the remaining half of PADE-treated and control males were mated with intact females. Two female rats were housed with one male for two estrus cycles. PADE effects on fertility and fetal/offspring development were evaluated.
Herein, we report that oral treatment of male Wistar rats with PADE before mating with intact females instigated marked effects on male reproductive organs. Treatment significantly decreased the motility of the sperm and increased the number of pathological forms of spermatozoa. Additionally, a dose-dependent effect on Leydig cells was observed. However, these PADE effects did not significantly affect male fertility nor fetal and offspring development when PADE-treated males were mated with intact females.
PADE treatment of male rates negatively affected sperm and testicular Leydig cell morphology. However, these changes did not affect male fertility and offspring development. It is currently not known whether PADE treatment may affect human male fertility and offspring development. Therefore, these results from an animal study need to be confirmed in humans. Results from this animal study can be used to model the exposure-response relationship and adverse outcomes in humans.
甲状腺功能障碍是一种常见的医学病症。如今,患者经常使用草药作为传统药物治疗的补充或替代选择。这些患者可能受益于用白委陵菜制剂治疗甲状腺功能障碍。虽然已经报道白委陵菜制剂的毒性较低,但对于其是否会影响育龄患者的生殖功能尚不清楚。
雄性 Wistar 大鼠经口给予甲状腺刺激植物药物,标准化白委陵菜干提取物(PADE),剂量分别为临床试验推荐中值治疗剂量的 8 倍和 40 倍,连续 60 天。给予水(HO)的雄性 Wistar 大鼠作为对照。完成治疗后,一半的 PADE 处理组和对照组雄性大鼠用于确定 PADE 的性腺毒性,另一半 PADE 处理组和对照组雄性大鼠与完整雌性大鼠交配。两只雌性大鼠与一只雄性大鼠交配两个发情周期。评估 PADE 对生育能力和胎儿/后代发育的影响。
在此,我们报告称,在与完整雌性大鼠交配前,雄性 Wistar 大鼠口服 PADE 治疗会对雄性生殖器官产生明显影响。治疗显著降低了精子的活力,并增加了精子的病理形态数量。此外,还观察到对莱迪希细胞的剂量依赖性影响。然而,当 PADE 处理的雄性大鼠与完整雌性大鼠交配时,这些 PADE 作用并未显著影响雄性生育能力或胎儿和后代发育。
PADE 处理雄性大鼠会对精子和睾丸莱迪希细胞形态产生负面影响。然而,这些变化不会影响雄性生育能力和后代发育。目前尚不清楚 PADE 治疗是否会影响人类男性的生育能力和后代发育。因此,这些动物研究的结果需要在人类中得到证实。这项动物研究的结果可用于在人类中建立暴露-反应关系和不良结局模型。